Перейти к основному содержанию

page search

Library Economic Benefits and Costs of Biotechnology Innovations in Agriculture

Economic Benefits and Costs of Biotechnology Innovations in Agriculture

Economic Benefits and Costs of Biotechnology Innovations in Agriculture

Resource information

Date of publication
декабря 2001
Resource Language
ISBN / Resource ID
AGRIS:US2016215376

The conceptual model necessary for an assessment of biotechnology's economic benefits and costs is outlined, emphasizing the need to account for the proprietary nature of biotechnology innovations. The model is illustrated with an application to Roundup Ready soybeans. The estimated value of this innovation is sizeable, with consumers and innovators claiming the larger share of net benefits. Also, disparities in intellectual property rights protection across countries affect the distribution of benefits. Consumer resistance toward genetically modified organisms (GMOs) and the issues of labeling and market segregation complicate the economic evaluation of biotechnology innovations, and a number of related regulation and public policy issues are discussed. Emerging output-trait GMOs are potentially less controversial and may bring more benefits to all participants in the agri-food sector, but this outcome depends crucially on the development of an effective, credible, and internationally harmonized regulatory system.

Share on RLBI navigator
NO

Authors and Publishers

Author(s), editor(s), contributor(s)

Moschini, GianCarlo

Publisher(s)
Data Provider